You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and United States Oncology Blood Testing Market Size, Status and Forecast 2020-2026

Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool.
Market Analysis and Insights: Global Oncology Blood Testing Market
The global Oncology Blood Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Blood Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Blood Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Blood Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Blood Testing market.
Oncology Blood Testing Breakdown Data by Type
Blood Protein Testing
Tumor Marker Testing
Others
Oncology Blood Testing Breakdown Data by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Based on regional and country-level analysis, the Oncology Blood Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Oncology Blood Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Blood Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Blood Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oncology Blood Testing Market Perspective (2015-2026)
2.2 Global Oncology Blood Testing Growth Trends by Regions
2.2.1 Oncology Blood Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oncology Blood Testing Historic Market Share by Regions (2015-2020)
2.2.3 Oncology Blood Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oncology Blood Testing Players by Market Size
3.1.1 Global Top Oncology Blood Testing Players by Revenue (2015-2020)
3.1.2 Global Oncology Blood Testing Revenue Market Share by Players (2015-2020)
3.2 Global Oncology Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Blood Testing Revenue
3.4 Global Oncology Blood Testing Market Concentration Ratio
3.4.1 Global Oncology Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Blood Testing Revenue in 2019
3.5 Key Players Oncology Blood Testing Area Served
3.6 Key Players Oncology Blood Testing Product Solution and Service
3.7 Date of Enter into Oncology Blood Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Blood Testing Breakdown Data by Type (2015-2026)
4.1 Global Oncology Blood Testing Historic Market Size by Type (2015-2020)
4.2 Global Oncology Blood Testing Forecasted Market Size by Type (2021-2026)

5 Oncology Blood Testing Breakdown Data by Application (2015-2026)
5.1 Global Oncology Blood Testing Historic Market Size by Application (2015-2020)
5.2 Global Oncology Blood Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Oncology Blood Testing Market Size (2015-2026)
6.2 North America Oncology Blood Testing Market Size by Type (2015-2020)
6.3 North America Oncology Blood Testing Market Size by Application (2015-2020)
6.4 North America Oncology Blood Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Oncology Blood Testing Market Size (2015-2026)
7.2 Europe Oncology Blood Testing Market Size by Type (2015-2020)
7.3 Europe Oncology Blood Testing Market Size by Application (2015-2020)
7.4 Europe Oncology Blood Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Oncology Blood Testing Market Size (2015-2026)
8.2 China Oncology Blood Testing Market Size by Type (2015-2020)
8.3 China Oncology Blood Testing Market Size by Application (2015-2020)
8.4 China Oncology Blood Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Oncology Blood Testing Market Size (2015-2026)
9.2 Japan Oncology Blood Testing Market Size by Type (2015-2020)
9.3 Japan Oncology Blood Testing Market Size by Application (2015-2020)
9.4 Japan Oncology Blood Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Oncology Blood Testing Market Size (2015-2026)
10.2 Southeast Asia Oncology Blood Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Oncology Blood Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Oncology Blood Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Details
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Oncology Blood Testing Introduction
11.1.4 Guardant Health Revenue in Oncology Blood Testing Business (2015-2020))
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Details
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Oncology Blood Testing Introduction
11.2.4 Trovagene Revenue in Oncology Blood Testing Business (2015-2020)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Oncology Blood Testing Introduction
11.3.4 Genomic Health Revenue in Oncology Blood Testing Business (2015-2020)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oncology Blood Testing Introduction
11.4.4 Roche Revenue in Oncology Blood Testing Business (2015-2020)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Details
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Oncology Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Oncology Blood Testing Business (2015-2020)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Details
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Oncology Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Oncology Blood Testing Business (2015-2020)
11.6.5 Pathway Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jul, 2020
  • NO OF PAGES: 134